{"transactions":[{"id":2946722,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-14T21:21:07.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":432432,"price":3.7,"value":1599998.4,"ownership":{"direct":true},"balance_after":3933429,"source":{"system":"sec-edgar","filing":"0001209191-20-063214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120063214/doc4.xml","form_type":"4"}},{"id":3105618,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-18T20:06:50.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":30000,"derivative":{"exercise_price":3.03,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-037558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919120037558/doc4.xml","form_type":"4"}},{"id":3454315,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T20:21:23.000Z","date":"2019-07-25","kind":"grant","acquired":true,"shares":677419,"price":4.65,"value":3149998.35,"ownership":{"direct":true},"balance_after":3500997,"source":{"system":"sec-edgar","filing":"0001209191-19-043479","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919119043479/doc4.xml","form_type":"4"}},{"id":3462548,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-12T21:05:23.000Z","date":"2019-06-14","kind":"gift","acquired":false,"shares":562715,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2823578,"source":{"system":"sec-edgar","filing":"0001209191-19-041954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919119041954/doc4.xml","form_type":"4"}},{"id":3489723,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-06-14T20:11:46.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 13, 2019 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":10000,"derivative":{"exercise_price":5.26,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-037117","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000120919119037117/doc4.xml","form_type":"4"}},{"id":3694617,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-16T18:07:49.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":3300,"price":32.1994,"value":106258.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form."}],"balance_after":3386293,"source":{"system":"sec-edgar","filing":"0000899243-19-001270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/doc4.xml","form_type":"4"}},{"id":3694616,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-16T18:07:49.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":1700,"price":31.6022,"value":53723.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $32.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":3389593,"source":{"system":"sec-edgar","filing":"0000899243-19-001270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319001270/doc4.xml","form_type":"4"}},{"id":3700453,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-08T21:05:41.000Z","date":"2019-01-07","kind":"sale","acquired":false,"shares":5000,"price":30.0813,"value":150406.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form."}],"balance_after":3391293,"source":{"system":"sec-edgar","filing":"0000899243-19-000742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924319000742/doc4.xml","form_type":"4"}},{"id":3729155,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-12-17T21:05:43.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":8165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 13, 2018 and vests in full on the earlier to occur of July 25, 2019 and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":8165,"derivative":{"exercise_price":23.58,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":8165},"source":{"system":"sec-edgar","filing":"0000899243-18-031202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318031202/doc4.xml","form_type":"4"}},{"id":3860967,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":144687,"kind":"person","name":"Arnold Matthew Bennett","position":1,"cik":"0001727991","reported_name":"Arnold Matthew Bennett","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option\n(Right to Buy)","published_at":"2018-07-26T22:54:00.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":1835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 25, 2018 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's first annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":1835,"derivative":{"exercise_price":37.89,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":1835},"source":{"system":"sec-edgar","filing":"0000899243-18-020709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1707502/000089924318020709/doc4.xml","form_type":"4"}}]}